History

Watch Varifarma’s Journey






Varifarma Through The Years

2023

Launch of Gorax and Anfonax . Agreement with SINOVAC for Argentina and Peru.

2022

Launching of Ultraciclib, Rupovar – Agreement with Biocon and Dr Reddy’s – Agreement with EUSA Pharma for Qarziba and Silvant - Agreement with Nanox for Nanotechnology Line.

2021

Agreement with Recordati for Signifor, Signifor LAR – Expansion of Rare Diseases Line – Opening new subsidiaries: Uruguay, Paraguay.

2020

Agreement with Recordati for Ledaga – Launching of Funomid, Suprol.

2019

Agreement with Aqvida and Aigen – Opening new subsidiaries: Chile, Perú, Ecuador - Launching of Lenvatib, Idelib Ponatib, Binap - Agreement with Adienne for Tepadina.

2018

Agreement with Myriad Genetics for Endopredict – Launching of Neurosciences Line.

2017

Acuerdo con Amgen para LATAM por Mvasi, Kanjinti.

2016

Agreement with Amgen for Blincyto, Xgeva.

2014

Agreement with Amgen for Neupogen, Neulastim, Aranesp.

2013

Launching of Relotib – Agreement with Onyx/Amgen for Kyprolis

2012

Argentina’s launching of Bendavar

2007

Agreement with Celgene for Vidaza

2005

Opening of our Manufacturing Plant

2004

Agreement with Octapharma for Hemostasis Portfolio.

2003

Agreement with Cassará Lab for Biotechnological Line.

1995

Opening of Laboratorio Varifarma, focusing on complex therapies.